We’re improving your experience!

×

Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.

Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.

Stay tuned for these updates, and thank you for being part of our community!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05361720
Title Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Vanderbilt-Ingram Cancer Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope National Medical Center RECRUITING Duarte California 91010 United States Details
Chao Family Comprehensive Cancer Center RECRUITING Orange California 92868 United States Details
University Hospitals Seidman Cancer Center RECRUITING Cleveland Ohio 44106 United States Details
Cleveland Clinic RECRUITING Cleveland Ohio 44195 United States Details
Vanderbilt University/Ingram Cancer Center RECRUITING Nashville Tennessee 37232 United States Details
University of Texas, Southwestern Medical Center RECRUITING Dallas Texas 75390 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field